6 мар. 2024 г. · The 2023 ACR guidelines suggest retesting if signs/symptoms of ILD develop and/or considering annual re-screening in high-risk patients.

2 авг. 2017 г. · AbstractObjective. The objective was to describe the methodology used to develop new response criteria for adult DM/PM and JDM.Methods.

High-dose intravenous (injection into a vein) or oral corticosteroids are first-line treatments. Symptoms and inflammation measures may start to improve in 2–4 ...

29 июн. 2023 г. · Traditionally, prednisone (0.5-2 mg/kg/d) up to a dose of 60 mg/d is given as initial therapy. The drug should be slowly tapered to avoid ...

To develop and validate new classification criteria for adult and juvenile idiopathic inflammatory myopathies (IIM) and their major subgroups.

31 мар. 2022 г. · Glucocorticoids are crucial for myositis remission induction and maintenance. Glucocorticoid dose should be weaned when disease activity, ... Scope and purpose · Recommendations · References

Treatments used for refractory disease include IVIG, cyclophosphamide, CsA, azathioprine, mycophenolate mofetil (MMF), hydroxychloroquine, tacrolimus, rituximab ...

6 апр. 2017 г. · Objective To develop response criteria for adult dermatomyositis (DM) and polymyositis (PM). Methods Expert surveys, logistic regression, ... Abstract · Methods · Results · Discussion

The first treatment for inflammatory myopathies is an oral corticosteroid, such as prednisone, at high dose. Muscle enzymes usually return to normal at 4 to 6 ...

19 мар. 2024 г. · Initial treatment of muscle disease is with high-dose oral corticosteroids, followed by the addition of immunosuppressants or intravenous ...